Lymphoproliferative response
Lymphoproliferative response refers to the process by which lymphocytes, a type of white blood cell, multiply in response to an antigen or other stimulus. This response is a crucial part of the immune system's defense against pathogens and other foreign substances.
Overview[edit]
The lymphoproliferative response begins when an antigen enters the body and is recognized by a specific lymphocyte. This recognition triggers the lymphocyte to proliferate, or multiply, creating a large number of identical cells that are all capable of responding to the same antigen. These cells include effector cells, which carry out the immune response, and memory cells, which remain in the body long-term and provide immunity against future encounters with the same antigen.
Mechanism[edit]
The lymphoproliferative response is initiated by the binding of an antigen to the antigen receptor on a lymphocyte. This binding activates the lymphocyte, causing it to enter the cell cycle and begin proliferating. The proliferation of lymphocytes is regulated by various factors, including cytokines, growth factors, and signals from other cells in the immune system.
Clinical significance[edit]
Abnormal lymphoproliferative responses can lead to a variety of health problems. For example, an overactive response can result in autoimmune diseases, where the immune system attacks the body's own cells. On the other hand, an underactive response can lead to immunodeficiency, where the immune system is unable to effectively fight off infections.
In addition, certain types of cancer, such as lymphoma and leukemia, are characterized by uncontrolled lymphocyte proliferation. These cancers can often be diagnosed by analyzing the patient's lymphoproliferative response.
See also[edit]
References[edit]
<references group="" responsive="1"></references>

This article is a immunology stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian